Copyright
        ©The Author(s) 2019.
    
    
        World J Hypertens. Mar 12, 2019; 9(1): 1-16
Published online Mar 12, 2019. doi: 10.5494/wjh.v9.i1.1
Published online Mar 12, 2019. doi: 10.5494/wjh.v9.i1.1
            Table 1 Causes of secondary hypertension and initial screening tests1
        
    | Hyperaldosteronism | Serum renin-aldosterone ratio | 
| Renal parenchymal disease | Serum creatinine | 
| Obstructive sleep apnea | Polysomnography | 
| Pheochromocytoma | Serum metanephrine and 24-h urine catecholamines | 
| Renal artery stenosis | Renal artery duplex | 
| Coarctation of the aorta | CT angiogram | 
| Cushing’s disease | 24-h free urinary cortisol and late-night salivary cortiso1 | 
| Thyroid disease | TSH and freeT4 | 
| Acromegaly | Serum growth hormone | 
| NSAIDs | 
| Estrogens/Progestins | 
| Anabolic Steroids | 
| Corticosteroids | 
| COX-2 Inhibitors | 
| SSRI/SNRI | 
| Tricyclic antidepressants | 
| Lithium | 
| Buspirone | 
| Carbamazepine | 
| Calcineurin inhibitors | 
| Pseudoephedrine | 
| Amphetamine derivatives | 
| 1Chemotherapy agents | 
| Caffeine | 
| Methamphetamines | 
| Cocaine | 
| Ginseng, St John’s Wort, Ephedra, Yohimbine | 
| Alcohol | 
- Citation: Schmidt K, Kelley W, Tringali S, Huang J. Achieving control of resistant hypertension: Not just the number of blood pressure medications. World J Hypertens 2019; 9(1): 1-16
- URL: https://www.wjgnet.com/2220-3168/full/v9/i1/1.htm
- DOI: https://dx.doi.org/10.5494/wjh.v9.i1.1

 
         
                         
                 
                 
                 
                 
                 
                         
                         
                        